Last update 29 Aug 2025
Demotech, Inc.

Demotech, Inc.

Startups
| Subsidiary Company|2014|Beijing Shi, China|
www.demo-tech.cn

Overview

Tags

Nervous System Diseases
Other Diseases
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Chemical drugs1

Related

2
Drugs associated with Demotech, Inc.
DM-0201
Target-
Mechanism-
Active Org.
Demotech, Inc.Demotech, Inc.
 [+1]
Originator Org.
Demotech, Inc.Demotech, Inc.
Active Indication
Neuralgia, Postherpetic
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
DM2080
Target-
Mechanism-
Active Org.
Demotech, Inc.Demotech, Inc.
Originator Org.
Demotech, Inc.Demotech, Inc.
Active Indication-
Inactive Indication-
Drug Highest PhaseIND Application
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Demotech, Inc.
CTR20243937
/ CompletedPhase 1
DM0201贴在中国健康受试者中单次/多次给药的药代动力学、安全性及耐受性研究
[Translation] Study on the pharmacokinetics, safety and tolerability of DM0201 patch after single/multiple administration in Chinese healthy subjects
100 Clinical Results associated with Demotech, Inc.
Login to view more data
0 Patents (Medical) associated with Demotech, Inc.
Login to view more data
100 Deals associated with Demotech, Inc.
Login to view more data
100 Translational Medicine associated with Demotech, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 Oct 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
1
2
IND Approval
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
DM-0201
Neuralgia, Postherpetic
More
Phase 1
DM0852
Soft tissue pain
More
IND Approval
DM2065
Osteoarthritis
More
IND Approval
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free